BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31258144)

  • 61. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity.
    Sabatier F; Roux V; Anfosso F; Camoin L; Sampol J; Dignat-George F
    Blood; 2002 Jun; 99(11):3962-70. PubMed ID: 12010795
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Arsenic trioxide induces procoagulant activity through phosphatidylserine exposure and microparticle generation in endothelial cells.
    Zhou J; Li H; Fu Y; Shi J; Hou J; Zhang Y; Liu X; Song P
    Thromb Res; 2011 May; 127(5):466-72. PubMed ID: 21272920
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CIRCULATING MICROPARTICLES, BLOOD CELLS, AND ENDOTHELIUM INDUCE PROCOAGULANT ACTIVITY IN SEPSIS THROUGH PHOSPHATIDYLSERINE EXPOSURE.
    Zhang Y; Meng H; Ma R; He Z; Wu X; Cao M; Yao Z; Zhao L; Li T; Deng R; Dong Z; Tian Y; Bi Y; Kou J; Thatte HS; Zhou J; Shi J
    Shock; 2016 Mar; 45(3):299-307. PubMed ID: 26513704
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of Epicatechin on the Procoagulant Activities of Microparticles.
    Sinegre T; Milenkovic D; Bourgne C; Teissandier D; Nasri Y; Dannus LT; Morand C; Lebreton A
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32992756
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women.
    Radu CM; Campello E; Spiezia L; Dhima S; Visentin S; Gavasso S; Woodhams B; Cosmi E; Simioni P
    Scand J Clin Lab Invest; 2015 Oct; 75(6):487-95. PubMed ID: 26067611
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Extracellular Ca(2+) suppresses endotoxin-inducible tissue factor activation in monocytic THP-1 cells.
    Chu AJ; Fox MJ; Prasad JK
    Cell Biochem Funct; 2000 Mar; 18(1):67-73. PubMed ID: 10686585
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Circulating microparticles in carriers of prothrombin G20210A mutation.
    Campello E; Spiezia L; Radu CM; Gavasso S; Zerbinati P; Woodhams B; Simioni P
    Thromb Haemost; 2014 Sep; 112(3):432-7. PubMed ID: 24816676
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The composition and daily variation of microparticles in whole blood in stable coronary artery disease.
    Christersson C; Lindahl B; Siegbahn A
    Scand J Clin Lab Invest; 2016; 76(1):25-32. PubMed ID: 26405844
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An innovative flow cytometric approach for small-size platelet microparticles: influence of calcium.
    Montoro-García S; Shantsila E; Orenes-Piñero E; Lozano ML; Lip GY
    Thromb Haemost; 2012 Aug; 108(2):373-83. PubMed ID: 22740162
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New observations on procoagulant properties of amniotic fluid: microparticles (MPs) and tissue factor-bearing MPs (MPs-TF), comparison with maternal blood plasma.
    Uszyński W; Zekanowska E; Uszyński M; Zyliński A; Kuczyński J
    Thromb Res; 2013; 132(6):757-60. PubMed ID: 24157083
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity.
    Lee RD; Barcel DA; Williams JC; Wang JG; Boles JC; Manly DA; Key NS; Mackman N
    Thromb Res; 2012 Jan; 129(1):80-5. PubMed ID: 21737126
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo.
    Mezouar S; Darbousset R; Dignat-George F; Panicot-Dubois L; Dubois C
    Int J Cancer; 2015 Jan; 136(2):462-75. PubMed ID: 24889539
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antithrombin Activity of Erythrocyte Microvesicles.
    Levin GY; Sukhareva EG
    Bull Exp Biol Med; 2017 Apr; 162(6):718-721. PubMed ID: 28429220
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Histones induce phosphatidylserine exposure and a procoagulant phenotype in human red blood cells.
    Semeraro F; Ammollo CT; Esmon NL; Esmon CT
    J Thromb Haemost; 2014 Oct; 12(10):1697-702. PubMed ID: 25069624
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Exposure of Phosphatidylserine Influences Procoagulant Activity in Retinal Vein Occlusion by Microparticles, Blood Cells, and Endothelium.
    Su Y; Deng X; Ma R; Dong Z; Wang F; Shi J
    Oxid Med Cell Longev; 2018; 2018():3658476. PubMed ID: 30057675
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Microparticles and blood cells induce procoagulant activity via phosphatidylserine exposure in NSTEMI patients following stent implantation.
    Wang L; Bi Y; Cao M; Ma R; Wu X; Zhang Y; Ding W; Liu Y; Yu Q; Zhang Y; Jiang H; Sun Y; Tong D; Guo L; Dong Z; Tian Y; Kou J; Shi J
    Int J Cardiol; 2016 Nov; 223():121-128. PubMed ID: 27537737
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Extracellular Histones Increase Tissue Factor Activity and Enhance Thrombin Generation by Human Blood Monocytes.
    Gould TJ; Lysov Z; Swystun LL; Dwivedi DJ; Zarychanski R; Fox-Robichaud AE; Liaw PC;
    Shock; 2016 Dec; 46(6):655-662. PubMed ID: 27405066
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Microparticle formation after exposure of blood to activated endothelium under flow.
    Macey MG; Wolf SI; Lawson C
    Cytometry A; 2010 Aug; 77(8):761-8. PubMed ID: 20653016
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.
    Somajo S; Koshiar RL; Norström E; Dahlbäck B
    Thromb Res; 2014 Jul; 134(1):144-52. PubMed ID: 24835672
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The presence and release of tissue factor from human platelets.
    Siddiqui FA; Desai H; Amirkhosravi A; Amaya M; Francis JL
    Platelets; 2002 Jun; 13(4):247-53. PubMed ID: 12189027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.